Mar 15, 2019 / Fact Sheets

Fact sheet on MedPAC’s March 2019 Report to the Congress: Medicare Payment Policy

Research Areas:

Ambulatory Care Settings, Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests, Hospitals, Medicare Spending and Financing, Physicians And Other Health Professionals, Post-Acute Care, Private Plans, Quality

Mar 15, 2019 / Press Releases

MedPAC releases March 2019 Report to the Congress: Medicare Payment Policy

Research Areas:

Ambulatory Care Settings, Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests, Hospitals, Medicare Spending and Financing, Physicians And Other Health Professionals, Post-Acute Care, Private Plans, Quality

Mar 07, 2019 / Presentations

Two Medicare payment strategies to improve price competition and value for Part B drugs: Reference pricing and binding arbitration

Research Areas:

Delivery System Reforms, Drugs, Devices, and Tests

Mar 01, 2019 / Chapters

Executive summary (March 2019 report)

Research Areas:

Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests, Hospitals, Physicians And Other Health Professionals, Post-Acute Care, Private Plans, Quality, Regional Issues

Mar 01, 2019 / Chapters

Chapter 16: Mandated report: Opioids and alternatives in hospital settings—Payments, incentives, and Medicare data (March 2019 report)

Research Areas:

Drugs, Devices, and Tests, Hospitals

Mar 01, 2019 / Chapters

Chapter 3: Hospital inpatient and outpatient services (March 2019 report)

Research Areas:

Hospitals, Medicare Spending and Financing, Quality

Jan 18, 2019 / Presentations

Future policy directions to address Medicare prescription drug spending

Research Areas:

Drugs, Devices, and Tests

Jan 17, 2019 / Presentations

Opioids and alternatives in hospital settings: Payments, incentives, and Medicare data

Research Areas:

Drugs, Devices, and Tests, Hospitals

Jan 16, 2019 / Comment Letters

MedPAC comment on CMS’s proposed rule on modernizing Part D and Medicare Advantage to lower drug prices and reduce OOP expenses

Research Areas:

Delivery System Reforms, Drugs, Devices, and Tests, Private Plans

Dec 18, 2018 / Comment Letters

MedPAC comment on CMS’s ANPRM on the International Pricing Index Model for Medicare Part B drugs

Research Areas:

Delivery System Reforms, Drugs, Devices, and Tests